Open Science publishing for the Drug Repurposing Community

Billions of dollars are wasted each year on non-reproducible biomedical research. The EU-funded drug repurposing initiative REPO4EU has embraced Open Science both to revolutionize how we approach drug discovery and how we communicate the results. The goal is to increase the reproducibility, interoperability, and reliability of the scholarly literature to streamline discoverability which in turn supports bioinformatics approaches, in-silico drug discovery, and precision medicine. Drug Repurposing Central is more than an open access journal, it is an open science communication platform for the whole drug repurposing community covering outputs ranging from conference abstracts to preprints and full open access journals. Drug Repurposing Central is:

Open: Creative Commons 4.0 Open access license
Rapid: Preprints, Community run Diamond OA journal
Interoperable: DOI, ORCID, Institutional ID ROR, FundRef ID, RRID
Reproducible: Scientific rigor report prior to publication, NISO Data availability statements
Inclusive: Open community review, lay summaries, user collections

Content

Author and article information

Conference

Title: RExPO24 Conference

Publisher: REPO4EU

Publication date (Electronic preprint): 25 July 2024

Affiliations

[1 ] ScienceOpen, Berlin, Germany;

Author notes

[* ]Email: stephanie.dawson@ 123456scienceopen.com .

Author information

Stephanie Dawson https://orcid.org/0000-0002-2298-2418

Article

DOI: 10.58647/REXPO.24000072.v1

SO-VID: 9a39cef4-ebd7-4db4-ad31-2d8a6cad3617

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

Conference name: RExPO24

Conference number: 3

Conference location: Munich, Germany

Conference date: 3-5 July 2024

History

Date received : 25 July 2024

Funding

Funded by: funder-id http://dx.doi.org/10.13039/100018696, HORIZON EUROPE Health;

Award ID: 101057619

References

Fraser Nicholas, Momeni Fakhri, Mayr Philipp, Peters Isabella. The effect of bioRxiv preprints on citations and altmetrics. Cold Spring Harbor Laboratory. [Cross Ref]

Comments

Comment on this article

[1] Fraser Nicholas, Momeni Fakhri, Mayr Philipp, Peters Isabella. The effect of bioRxiv preprints on citations and altmetrics. Cold Spring Harbor Laboratory. [Cross Ref]